Skip to main content

Advertisement

SpringerLink
Log in

Identification and validation of a novel nine-gene prognostic signature of stem cell characteristic in hepatocellular carcinoma

  • Human Genetics • Original Paper
  • Published:
Journal of Applied Genetics Aims and scope Submit manuscript

Abstract

Currently, cancer stem cells (CSCs) are regarded as the most promising target for cancer therapy due to their close association with tumor resistance, invasion, and recurrence. Thus, identifying CSCs-related genes and constructing a prognostic risk model associated with CSCs may be crucial for hepatocellular carcinoma (HCC) therapy. Xena Browser was used to download gene expression profiles and clinical data, while MSigDB was used to obtain genes associated with CSCs. Firstly, the non-negative matrix factorization (NMF) algorithm was used to cluster the HCC samples based on CSCs-related genes. To evaluate the predictive performance of the risk model, the receiver operating characteristic curves (ROC) and Kaplan–Meier analysis were used. The R package “rms” was used to construct the final nomogram based on risk scores and clinical characteristics. Based on 449 CSCs-related genes, a total of 588 HCC samples from TCGA-LIHC and ICGC-LIRI_JP were classified into four molecular subtypes with marked differences in survival and mRNA stemness index (mRNAsi) between subtypes. Univariate Cox regression, multivariate Cox regression, and LASSO regression analyses were performed on a total of 1417 differentially expressed genes (DEGs) between subtypes, and a nine-gene prognostic model was constructed with TTK, ST6GALNAC4, SPP1, SGCB, MEP1A, HTRA1, CD79A, C6, and ATP2A3. In both the training and testing sets and the external validation cohort, the risk model performed well in predicting HCC patients’ survival. A nomogram was constructed and had high predictive efficacy in short-term survival. In comparison with the other two prognostic models, our nine-gene signature model performed best. We constructed a nine-gene signature model to predict the survival of HCC patients, which has good predictive efficacy and stability. The model may contribute to guiding the prognostic assessment of HCC patients in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

The data used to support this study are available from the corresponding author upon request. Declarations.

References

  • Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16(4):e173–e180

    Article  PubMed  PubMed Central  Google Scholar 

  • Bayik D, Lathia JD (2021) Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer 21(8):526–536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Calderaro J, Ziol M, Paradis V et al (2019) Molecular and histological correlations in liver cancer. J Hepatol 71(3):616–630

    Article  CAS  PubMed  Google Scholar 

  • Carter H, Samayoa J, Hruban RH et al (2010) Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). Cancer Biol Ther 10(6):582–587

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cojoc M, Mäbert K, Muders MH, Dubrovska A (2015) A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol 31:16–27

    Article  CAS  PubMed  Google Scholar 

  • Ferguson LP, Diaz E, Reya T (2021) The role of the microenvironment and immune system in regulating stem cell fate in cancer. Trends Cancer 7(7):624–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hernández-Oliveras A, Izquierdo-Torres E, Meneses-Morales I et al (2019) Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator. Int J Biochem Cell Biol 113:8–16

    Article  PubMed  Google Scholar 

  • Hu B, Yang XB, Sang XT (2020) Development of an immune-related prognostic index associated with hepatocellular carcinoma. Aging 12(6):5010–5030

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hugonnet M, Singh P, Haas Q et al (2021) The distinct roles of sialyltransferases in cancer biology and onco-immunology. Front Immunol 12:799861

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee JH, Suh JH, Choi SY et al (2019) Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence, and metastasis. Gut 68(2):347–358

    Article  CAS  PubMed  Google Scholar 

  • Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M (2021) The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer 21(9):541–557

    Article  CAS  PubMed  Google Scholar 

  • Liang Y, Su Q, Wu X (2021) Identification and validation of a novel six-gene prognostic signature of stem cell characteristic in colon cancer. Front Oncol 10:571655

    Article  PubMed  PubMed Central  Google Scholar 

  • Lin CC, Lo MC, Moody R et al (2018) Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer. Cancer Lett 438:165–173

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu GM, Zeng HD, Zhang CY, Xu JW (2019) Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int 19:138

    Article  PubMed  PubMed Central  Google Scholar 

  • Liu YC, Yeh CT, Lin KH (2020) Cancer stem cell functions in hepatocellular carcinoma and comprehensive therapeutic strategies. Cells 9(6):1331

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Llovet JM, Kelley RK, Villanueva A et al (2021) Hepatocellular Carcinoma. Nat Rev Dis Primers 7(1):6

    Article  PubMed  Google Scholar 

  • Luger D, Yang YA, Raviv A et al (2013) Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects. PLoS ONE 8(10):e76115

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  • Ma L, Hernandez MO, Zhao Y et al (2019) Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell 36(4):418-430.e6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Malta TM, Sokolov A, Gentles AJ et al (2018) Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173(2):338–354

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Maugeri-Saccà M, Vigneri P, De Maria R (2011) Cancer stem cells and chemosensitivity. Clin Cancer Res 17(15):4942–4947

    Article  PubMed  Google Scholar 

  • Meneses-Morales I, Izquierdo-Torres E, Flores-Peredo L et al (2019) Epigenetic regulation of the human ATP2A3 gene promoter in gastric and colon cancer cell lines. Mol Carcinog 58(6):887–897

    Article  CAS  PubMed  Google Scholar 

  • Olesen SH, Thykjaer T, Orntoft TF (2001) Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity. Carcinogenesis 22:813–815

    Article  CAS  PubMed  Google Scholar 

  • Oulas A, Minadakis G, Zachariou M et al (2019) Systems bioinformatics: increasing precision of computational diagnostics and therapeutics through network-based approaches. Brief Bioinform 20(3):806–824

    Article  CAS  PubMed  Google Scholar 

  • Sahin IH, Askan G, Hu ZI, O’Reilly EM (2017) Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity? Ann Oncol 28(12):2950–2961

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S et al (2012) Identification of osteopontin as a novel marker for early hepatocellular carcinoma. Hepatology 55:483–490

    Article  CAS  PubMed  Google Scholar 

  • Shevchenko V, Arnotskaya N, Zaitsev S et al (2020) Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma. Int Rev Neurobiol 151:185–200

    Article  CAS  PubMed  Google Scholar 

  • Shooshtarizadeh P, Helness A, Vadnais C et al (2019) Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes. Nat Commun 10(1):1270

    Article  ADS  PubMed  PubMed Central  Google Scholar 

  • de Sousa e Melo F, Kurtova AV, Harnoss JM (2017) A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature 543(7647):676–680

  • Tsai YM, Wu KL, Chang YY et al (2020) Upregulation of Thr/Tyr kinase increases the cancer progression by neurotensin and dihydropyrimidinase-like 3 in lung cancer. Int J Mol Sci 21(5):1640

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Q, Liang N, Yang T et al (2021) DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. J Hepatol 75(5):1142–1153

    Article  CAS  PubMed  Google Scholar 

  • Wang Z, Liao J, Wu S et al (2016) Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population. Cancer Gene Ther 23(6):157–161

    Article  CAS  PubMed  Google Scholar 

  • Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589–604

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471003, China

    Yahang An, Weifeng Liu, Yanhui Yang, Zhijie Chu & Junjun Sun

Authors
  1. Yahang An
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Weifeng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yanhui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhijie Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junjun Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Yahang An designed the study and wrote the manuscript. Weifeng Liu, Yanhui Yang, and Zhijie Chu contributed to the statistical analysis. Junjun Sun reviewed and funded the manuscript.

Corresponding author

Correspondence to Junjun Sun.

Additional information

Communicated by Ewa Ziętkiewicz.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

An, Y., Liu, W., Yang, Y. et al. Identification and validation of a novel nine-gene prognostic signature of stem cell characteristic in hepatocellular carcinoma. J Appl Genetics (2024). https://doi.org/10.1007/s13353-024-00850-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13353-024-00850-7

Keywords

Search

Navigation